UNFAIR DEAL
After Japanese, American haemophiliacs have followed suit. They have turned down aUS $640 million settlement offer made by four major drug companies. An estimated 10,000 haemophiliacs in the US contracted the AIDS virus by injecting tainted blood-clotting products made by the companies in the early '80s. Attorneys representing the haemophiliacs said that the offer made last month was too low to set tie the claims. They are citing the case of Japanese haemophiliacs who are receiving higher claims. The four drug companies involved in the suit are, Bayer AG, Baxter International Inc, Rhone-Poulenc, Rorer Inc and Alpha Therapeutics Inc.
Related Content
- Safeguarding and enhancing land-based livelihoods: social protection and land governance in Mozambique
- US challenges India's solar energy policy before WTO
- Development-led globalization: towards sustainable and inclusive development paths
- Labour and employment under Globalisation: The case of Gujarat
- Give small players in food retail a new deal
- Acting pricey,Why is a tonne of tradable carbon worth US $5 in India and US $27 in Europe?